GE HealthCare Launches Multi-Purpose Versana Premier Ultrasound

News
Article

The new ultrasound platform reportedly offers a combination of enhanced imaging and AI-enabled tools to facilitate improved workflow efficiency.

The emerging artificial intelligence (AI)-enabled ultrasound system Versana Premier may promote improved imaging and efficiency across a variety of clinical settings.

In addition to fostering up to a 38 percent improvement in workflow efficiency, the Versana Premier ultrasound offers Whizz technology that offers real-time image optimization, according to GE HealthCare, the manufacturer of Versana Premier.

GE HealthCare Launches Multi-Purpose Versana Premier Ultrasound

The newly launched Versana Premier ultrasound device reportedly offers automated labeling for transabdominal ultrasound views and provides 3D/4D capabilities for capturing fetal development, according to GE HealthCare, the manufacturer of Versana Premier. (Image courtesy of GE HealthCare.)

The company noted the FDA-cleared ultrasound device also provides AI-powered automated labeling for transabdominal ultrasound views as well as volume calculations. For OBGYN imaging, GE HealthCare said the Versana Premier features Whizz RenderLive and V-Live 2.0 enable clinicians to obtain 3D and 4D imaging of fetal development.

“Versana Premier is remarkably user-friendly and image quality in B-Mode is easy to optimize, making it possible to create amazing images," said Martin Altersberger, M.D., the director of the Echo Laboratory at State Hospital Steyr in Steyr, Austria. "The ultrasound system integrates advanced functions with optimized image quality and educational resources, which can be used in various settings. It can, therefore, adequately support clinicians in a wide range of assessments and diagnoses.”

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.